(Q34202954)

31 July 2017

0 references

1 reference

title

A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients (English)

1 reference

31 July 2017

0 references

0 references

1 reference

Ian Needleman

4

1 reference

ORCID Public Data File 2021

author name string

David Herrera

1

1 reference

31 July 2017

Mariano Sanz

2

1 reference

31 July 2017

Soren Jepsen

3

1 reference

31 July 2017

Silvia Roldán

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Journal of Clinical Periodontology

31 July 2017

published in

1 reference

31 July 2017

volume

29 Suppl 3

1 reference

31 July 2017

page(s)

136-59; discussion 160-2

1 reference

Non-surgical pocket therapy: pharmacotherapeutics

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

A review of longitudinal studies that compared periodontal therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

The influence of supragingival plaque control on clinical and microbial outcomes following the use of antibiotics for the treatment of periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Non-surgical periodontal treatment with and without adjunctive metronidazole in smokers and non-smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

A role for antibiotics in the treatment of refractory periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Macrolides and changes in the oral flora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Effects of a combination therapy to eliminate Porphyromonas gingivalis in refractory periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Efficacy of clindamycin hydrochloride in refractory periodontitis: 24-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Efficacy of clindamycin hydrochloride in refractory periodontitis. 12-month results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Clinical and microbiological evaluation of therapy for juvenile periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Periodontal Therapy in Humans: I. Microbiological and Clinical Effects of a Single Course of Periodontal Scaling and Root Planing, and of Adjunctive Tetracycline Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Gingival healing. V. The effects of antibiotics administered during the early stages of repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

The effect of clindamycin on the microbiota associated with refractory periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Microbiological and Clinical Results of Metronidazole Plus Amoxicillin Therapy in Actinobacillus actinomycetemcomitans‐Associated Periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Effects of metronidazole on periodontal treatment needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Persistent bacterial colonization of Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans in periodontitis and its association with alveolar bone loss after 6 months of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Yeasts in juvenile periodontitis. Preliminary observations by scanning electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Effect of periodontal therapy on alveolar bone as measured by subtraction radiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Effect of therapy on periodontal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

Consensus report. Periodontal diseases: pathogenesis and microbial factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Consensus report. Non-surgical pocket therapy: mechanical, pharmacotherapeutics, and dental occlusion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effects of adjunctive treatment of periodontitis with tetracycline and spiramycin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Development of a classification system for periodontal diseases and conditions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Comparison of spiramycin and tetracycline used adjunctively in the treatment of advanced chronic periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effectiveness of Routine Periodontal Treatment With and Without Adjunctive Metronidazole Therapy in a Sample of Mentally Retarded Adolescents

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Meta-analysis of the effect of systemic metronidazole as an adjunct to scaling and root planing for adult periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clinical, microbiological and immunological features of subjects with refractory periodontal diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Quality assessment and meta-analysis of systemic tetracycline use in chronic adult periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The effect of tetracycline and/or scaling on human periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Systemic metronidazole in the treatment of periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effect of metronidazole on chronic periodontal disease in subjects using a topically applied chlorhexidine gel

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

A follow-up study 3 years after metronidazole therapy for chronic periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

A randomized, placebo-controlled trial of doxycycline: effect on the microflora of recurrent periodontitis lesions in high risk patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Use of metronidazole as a probe in the study of human periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effect of long-term tetracycline therapy on human periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effect of tetracycline and/or scaling on human periodontal disease. Clinical, microbiological, and histofogical observations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Metronidazole in periodontitis (IV). The effect of patient compliance on treatment parameters

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Treatment of subjects with refractory periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high-risk patients: antimicrobial activity and collagenase inhibition

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The bacteria of periodontal diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Microbial and clinical measurements of periodontal pockets during sequential periods of non-treatment, mechanical debridement and metronidazole therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Adjunctive systemic and locally delivered metronidazole in the treatment of periodontitis: a controlled clinical study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

On the inability of root debridement and periodontal surgery to eliminate Actinobacillus actinomycetemcomitans from periodontal pockets

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Metronidazole in the treatment of localized juvenile periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

A 2-step non-surgical procedure and systemic antibiotics in the treatment of rapidly progressive periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The effect of systemic metronidazole after non-surgical treatment in moderate and advanced periodontitis in young adults

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clinical and microbiological effects of initial periodontal therapy in conjunction with amoxicillin and clavulanic acid in patients with adult periodontitis. A randomised double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Systemic antibiotic therapy in periodontics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clinical experiences with tetracyclines in the treatment of periodontal diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Safety and efficacy of sub-antimicrobial-dose doxycycline therapy in patients with adult periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Role of anaerobic bacteria in periodontal disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Amoxycillin with clavulanic acid and tetracycline in periodontal therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Analysis of gingival crevicular fluid intracytoplasmic enzyme activity in patients with adult periodontitis and rapidly progressive periodontitis. A longitudinal study model with periodontal treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Actinobacillus actinomycetemcomitans in destructive periodontal disease. Three-year follow-up results

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Suppression of subgingival Actinobacillus actinomycetemcomitans in localized juvenile periodontitis by systemic tetracycline

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Treatment of periodontal disease based on microbiological diagnosis. A 5-year follow-up on individual patterns

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Doxycycline-resistant bacteria in periodontally diseased individuals after systemic doxycycline therapy and in healthy individuals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Gingival Crevicular Fluid Concentration and Side Effects of Minocycline: A Comparison of Two Dose Regimens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effects of short-term administration of metronidazole on the subgingival microflora

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The role of Actinobacillus actinomycetemcomitans in periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Combined antibiotic (metronidazole) and mechanical treatment effects on the subgingival bacterial flora of sites with recurrent periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effect of modified Widman flap surgery and systemic tetracycline on the subgingival microbiota of periodontal lesions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clinical, microbiological and immunological features associated with the treatment of active periodontosis lesions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Putative periodontal pathogens, antibody titres and avidities to them in a longitudinal study of patients with resistant periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Intraoral persistence of Actinobacillus actinomycetemcomitans in periodontally healthy subjects following treatment of diseased family members

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The effect of metronidazole on human periodontal disease. A clinical and bacteriological study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Treatment of localized juvenile periodontitis. Results after 5 years

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Treatment of periodontal infections due to anaerobic bacteria with short-term treatment with metronidazole

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effect of combined systemic antimicrobial therapy and mechanical plaque control in patients with recurrent periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effect of non-surgical periodontal therapy combined with adjunctive antibiotics in subjects with "refractory" periodontal disease. (I). Clinical results.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Microbiological and clinical effects of surgery plus doxycycline on juvenile periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Treatment of recurrent periodontal disease by root planing and Ornidazole (Tiberal). Clinical and microbiological findings

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Failure of adjunctive minocycline-HCl to eliminate oral Actinobacillus actinomycetemcomitans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

A 2-year study of adjunctive minocycline-HCl in Actinobacillus actinomycetemcomitans-associated periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Refractory chronic periodontitis: effect of oral tetracycline hydrochloride and root planning

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomycetemcomitans-associated periodontitis. A 2-year evaluation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Bacterial resistance following subgingival and systemic administration of minocycline

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Subgingival occurrence of enteric rods, yeasts and staphylococci after systemic doxycycline therapy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Long-term effects of microbiologically modulated periodontal therapy on advanced adult periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Treatment of periodontal disease based on microbiological diagnosis. Relation between microbiological and clinical parameters during 5 years

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Suppression of penicillin-resistant oral Actinobacillus actinomycetemcomitans with tetracycline. Considerations in endocarditis prophylaxis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effect of spiramycin therapy on human periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Periodontitis patient and the spouse: periodontal bacteria before and after treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clinical and microbiologic effects of single-dose metronidazole or scaling and root planing in treatment of adult periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effects of metronidazole in patients with "refractory" periodontitis associated with Bacteroides forsythus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Serial doxycycline and metronidazole in prevention of recurrent periodontitis in high-risk patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Short-term sequential administration of amoxicillin/clavulanate potassium and doxycycline in the treatment of recurrent/progressive periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The immediate efficacy of adjunctive doxycycline in treatment of localized juvenile periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The effect of non-surgical periodontal and adjunctive minocycline-HCL treatments on the activity of salivary proteases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The effect of short-term administration of minocycline HCl on gingival inflammation and subgingival microflora

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Systemic doxycycline administration in the treatment of periodontal infections (I). Effect on the subgingival microbiota

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Systemic doxycycline administration in the treatment of periodontal infections (II). Effect on antibiotic resistance of subgingival species

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Metronidazole in periodontitis: reduced need for surgery

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clinical evaluation of spiramycin and erythromycin in control of periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

A rationale for the management of periodontal diseases: effects of tetracycline on subgingival bacteria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Tetracycline: a clinical study to determine its effectiveness as long-term adjuvant

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Metronidazole as an adjunct to periodontal therapy with sub-gingival curettage

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effect of systemic doxycycline administration on the subgingival microbial flora: a dark-field microscopy study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Protective effect of serum antibodies against a 110-kilodalton protein of Actinobacillus actinomycetemcomitans following periodontal therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clonal infection with Actinobacillus actinomycetemcomitans following periodontal therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Differential effects of systemic metronidazole and amoxicillin on Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in intraoral habitats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Collagenase activity in recurrent periodontitis: relationship to disease progression and doxycycline therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The effect of metronidazole therapy on human periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The utility of the BANA test for monitoring anaerobic infections due to spirochetes (Treponema denticola) in periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Nonsurgical treatment of patients with periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Metronidazole therapy for periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Chemotherapy in the Treatment of Periodontopathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Azithromycin in the treatment of periodontal disease. Effect on microbial flora

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Long-term sub-antimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis: effects on subgingival bacterial population dynamics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Periodontal regeneration of human intrabony defects with bioresorbable membranes. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

A clinical evaluation of the benefits of a course of oral penicillin following periodontal surgery

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Factors associated with different responses to periodontal therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Response to periodontal therapy in patients with high or low levels of P. gingivalis, P. intermedia, P. nigrescens and B. forsythus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Fluoroquinolones in the treatment of Actinobacillus actinomycetemcomitans-associated periodontitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

A clinical trial of phenoxymethyl penicillin for adjunctive treatment of juvenile periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Guided tissue regeneration and anti-infective therapy in the treatment of class II furcation defects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The value of systemically administered metronidazole in the modified Widman flap procedure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Systemic antimicrobial treatment and guided tissue regeneration. Clinical and microbiological effects in furcation defects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Periodontal pathogens on polytetrafluoroethylene membrane for guided tissue regeneration inhibit healing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Guided tissue regeneration in the treatment of degree III furcation defects in maxillary molars

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Guided tissue regeneration in the treatment of degree II furcations in maxillary molars.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The long-term efficacy of systemic doxycycline medication in the treatment of localized juvenile periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Longitudinal effect of non-surgical treatment and systemic metronidazole for 1 week in smokers and non-smokers with refractory periodontitis: a 5-year study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Clinical and microbiological effects of adjunctive antibiotics in treatment of localized juvenile periodontitis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Effects of penicillin and erythromycin on the clinical parameters of the periodontium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

The effect of long-term low-dose tetracycline therapy on the subgingival microflora in refractory adult periodontitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Interleukin-1 haplotype and periodontal disease progression following therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

Treatment of periodontal disease in diabetics reduces glycated hemoglobin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.29.S3.8.X

7 January 2021

10.1034/J.1600-051X.29.S3.8.X

Identifiers

DOI

1 reference

31 July 2017

1 reference